Tenax Therapeutics Stock Price. Everything You Need To Know About The Tenax Therapeutics Stock!
Tenax Therapeutics, Inc. is a pharmaceutical company that specializes in developing innovative treatments for life-threatening conditions. With headquarters in Chapel Hill, North Carolina, the company employs 7 full-time employees and offers two products, TNX-103 and TNX-201.
The firm’s lead product, Levosimendan, is a calcium sensitizer/K-ATP activator designed for use in hospitalized patients with acutely decompensated heart failure. Clinical trials have shown promising results, demonstrating its potential to improve cardiac function and decrease mortality rates in these patients. TNX-201 is another promising product aimed at treating pulmonary arterial hypertension (PAH), a fatal orphan disease.
Tenax Therapeutics, Inc. has completed Phase II clinical trials of Levosimendan in North America for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). The company is committed to further research and development to bring these products to market and improve patient outcomes. It’s vital to stay up-to-date with Tenax Therapeutics, Inc.’s progress and ongoing research in the stock market to make informed decisions regarding your investment portfolio.
Tenax Therapeutics Stock Price. Everything You Need To Know About The Tenax Therapeutics Stock! performance
- Employees 7
- Company HQ Chapel Hill
- Website http://www.tenaxthera.com/
- TENX Asset Type Common Stock
- TENX Market Capitalization 7M
- Earnings Per Share -31.04
- Dividends Per Share None
- Dividend Date 2018-02-26
- Quarterly Earnings Growth 0
Are you from Malaysia, Thailand, Indonesia, or Vietnam and looking to invest in global stocks? Look no further than Tenax Therapeutics, a promising stock in the healthcare sector. Tenax Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of products for critical care. With their innovative therapies, they aim to address significant unmet medical needs and improve patient outcomes. Investing in Tenax Therapeutics from Malaysia, Thailand, Indonesia, or Vietnam is easily accessible through Zorion, an investment platform that provides real US stock and Pre-IPO investment opportunities. Zorion offers investment insights and recommendations to help retail investors make informed decisions. Additionally, you can access educational materials and resources to further enhance your investment knowledge. Invest in Tenax Therapeutics today and be a part of the revolution in healthcare. Take advantage of the opportunities available at Zorion and make your investment journey a successful one.
